Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
about
Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study.Histogram analysis parameters of dynamic contrast-enhanced magnetic resonance imaging can predict histopathological findings including proliferation potential, cellularity, and nucleic areas in head and neck squamous cell carcinoma.Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma
P2860
Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Multiparametric imaging using ...... reated with chemoradiotherapy.
@en
Multiparametric imaging using ...... reated with chemoradiotherapy.
@nl
type
label
Multiparametric imaging using ...... reated with chemoradiotherapy.
@en
Multiparametric imaging using ...... reated with chemoradiotherapy.
@nl
prefLabel
Multiparametric imaging using ...... reated with chemoradiotherapy.
@en
Multiparametric imaging using ...... reated with chemoradiotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Multiparametric imaging using ...... reated with chemoradiotherapy.
@en
P2093
Cheng-Lung Hsu
Chia-Hsun Hsieh
Chien-Yu Lin
Chun-Ta Liao
Hung-Ming Wan
Jiun-Jie Wang
Kai-Ping Chang
Nai-Ming Cheng
Sheng-Chieh Chan
Shu-Hang Ng
P2860
P304
62606-62621
P356
10.18632/ONCOTARGET.15904
P407
P577
2017-03-04T00:00:00Z